StockData
Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO) stock

ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3027% below fair value
$2.60+0.00 (0.00%)

Close on Nov 17, 2026Market cap $148.68MP/E –Yield –

Abeona Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Abeona Therapeutics's pe ratio was 6.5× on Jul 31, 2026, against 7.7× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 20266.5×+3.1
2025Dec 31, 20253.4×−4.4
2014Apr 30, 20147.7×+7.5
2013Dec 31, 20130.3×–

More Abeona Therapeutics figures

See a number that looks wrong?